Kim McEachron

All filings by Kim McEachron on record concern Genomic Health Inc. Over a trading history stretching from 15 February 2016 to 8 November 2019, the count stands at 15 filings.

Every open-market trade on record is a sale: 2 sales worth €1.1M. The rest of the record consists of 8 share grants and 3 option exercises. So far in 2019, the count stands at no purchases and 2 sales.

On 14 November 2019 came the latest disclosure, a transaction in Genomic Health Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.